Sitat Opprinnelig skrevet av Kevlin Vis post
Iiiiiiiiik - "Regrowth of hair" var vel ikke det mest oppsiktsvekkende med den Damen

Vi snakker virkelig om en gammel & GOD medisin ..for de som VIL høre og se:
Hallo-o er det noen leger eller helsedirektoroter her inne å leser
Det er bare det at "den gode gamle" ikke lar seg patentbeskyttes (gjetter jeg pga alderen på legemiddlet) og dermed er inntjeningspotensialet SÅÅÅÅ mye mindre...

Les gjerne http://thyroid.about.com/cs/expertin...4t3woliner.htm

Pharmaceutical companies influence medical decisions in a way that encourages the use of newer patentable therapies at the expense of older (but perhaps equally effective and less expensive) therapies. “It begins on the first day of medical school and lasts through to retirement … It starts slowly and insidiously, like an addiction, and can end up influencing the very nature of medical decision-making and practice … Attempts to influence the judgment of doctors by commercial interests serving the medical industrial complex are nothing if not thorough.”

Armour Thyroid, one of many combination T4/T3 medications has been available for over 100 years. There is no patent protection for Armour Thyroid and there are many competing T4/T3 brands as well as generic versions of Armour available on the market. There are no “new” studies comparing Armour Thyroid to other thyroid medications. There are no journal, magazine or television advertisements regarding this therapeutic option. There are no sales representatives calling on physicians to prescribe Armour Thyroid. Is it any wonder that combination T4/T3 therapy has fallen out of favor?
Og hva ville være billigere enn å foreskrive "slakteavfall" for stoffskiftesyke?